fbpx

Female pattern hair loss is very common. Women’s hair loss can result in psychological distress, work-related difficulties, and familial troubles. Health Canada has authorized topical minoxidil to treat female hair loss. However, they did not authorize oral androgen receptor antagonists and blockers (spironolactone and cyproterone acetate), as well as 5-alpha reductase inhibitors (finasteride and dutasteride). These treatments have been associated with adverse effects and low compliance, and their long-term safety profile is uncertain.

 

Protocol for Hair Loss Treatment

Six Er:YAG laser treatments were performed on the patient at two-week intervals. This patient was treated with the Fotona SP Dynamis 2940nm Er: YAG laser. The handpiece parameters were R11, SMOOTH mode pulse, 2J/cm2, 1.6Hz. There were no side effects or pain associated with the laser therapy during or after the procedure. A follow-up session was planned eight months after the initial treatment. The patient’s hair loss had halted, and his density had improved. On the patient’s subjective hair growth evaluation measure, a 26–50% improvement was seen. The 7-point assessment scale was equal to a small increase.

before hair loss After hair loss

Address: 

12914 167 Ave NW

Edmonton, AB.

Canada T6V1J6

info@albanylaser.ca